Goosby discusses global AIDS fight at CSIS event

NewsGuard 100/100 Score

Ambassador Eric Goosby, the U.S. global AIDS coordinator, said that a recent $75 million pledge from the Bill & Melinda Gates Foundation, Chevron and Johnson & Johnson could help "eliminate new HIV-infected children by 2015 and keep mothers alive," McClatchy/News & Observer reports.

"Goosby's comments followed the annual United Nations High Level Meeting on AIDS earlier this month, where world leaders launched a global plan to end mother-to-child HIV transmission," the news service reports. "Goosby told an audience at the Center for Strategic and International Studies, a Washington think tank, that [PEPFAR] has been successful. Each country has seen roughly a 40 percent decrease in deaths since receiving PEPFAR help, he said," the news service reports. Goosby called for other countries to do more to fight HIV/AIDS wordwide. "We need to challenge our colleagues in Europe and the rest of the world to play their part," he said (Patrick, 6/28). A video of the event is available from CSIS (6/28).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer